Connection

Contact Us
If you have any questions or feedback please contact us.

Search Results to Virginia F. Borges

This is a "connection" page, showing the details of why an item matched the keywords from your search.

Search Results

Borges, Virginia

One or more keywords matched the following items that are connected to Borges, Virginia

Item Type	Name
Academic Article	A perimenopausal woman with a small, ER/HER2-positive, node-negative breast cancer.
Academic Article	Pregnancy and breast cancer: when they collide.
Academic Article	A woman with primary breast cancer and a solitary sternal metastasis.
Academic Article	Fulvestrant: a unique antiendocrine agent for estrogen-sensitive breast cancer.
Academic Article	Postpartum diagnosis demonstrates a high risk for metastasis and merits an expanded definition of pregnancy-associated breast cancer.
Concept	Neoplasm Metastasis
Concept	Lymphatic Metastasis
Academic Article	Cyclooxygenase-2-dependent lymphangiogenesis promotes nodal metastasis of postpartum breast cancer.
Academic Article	Management of young breast cancer patients with de novo genetic mutations.
Academic Article	Dermoscopic patterns of melanoma metastases: interobserver consistency and accuracy for metastasis recognition.
Academic Article	Local Therapy Decision-Making and Contralateral Prophylactic Mastectomy in Young Women with Early-Stage Breast Cancer.
Academic Article	Phase I Study of ONT-380, a HER2 Inhibitor, in Patients with HER2+-Advanced Solid Tumors, with an Expansion Cohort in HER2+ Metastatic Breast Cancer (MBC).
Academic Article	The Rodent Liver Undergoes Weaning-Induced Involution and Supports Breast Cancer Metastasis.
Academic Article	Rationale of technical requirements for NRG-BR001: The first NCI-sponsored trial of SBRT for the treatment of multiple metastases.
Academic Article	The 21-Gene Recurrence Score Assay for Node-Positive, Early-Stage Breast Cancer and Impact of RxPONDER Trial on Chemotherapy Decision-Making: Have Clinicians Already Decided?
Grant	NSAIDs During Postpartum Involution for Breast Cancer Chemoprevention
Academic Article	Development of Novel Patient-Derived Xenografts from Breast Cancer Brain Metastases.
Academic Article	Tucatinib with capecitabine and trastuzumab in advanced HER2-positive metastatic breast cancer with and without brain metastases: a non-randomised, open-label, phase 1b study.
Academic Article	Tucatinib Combined With Ado-Trastuzumab Emtansine in Advanced ERBB2/HER2-Positive Metastatic Breast Cancer: A Phase 1b Clinical Trial.
Academic Article	Semaphorin 7A Promotes Macrophage-Mediated Lymphatic Remodeling during Postpartum Mammary Gland Involution and in Breast Cancer.
Academic Article	Association Between Postpartum Breast Cancer Diagnosis and Metastasis and the Clinical Features Underlying Risk.
Academic Article	Estradiol induces BDNF/TrkB signaling in triple-negative breast cancer to promote brain metastases.
Academic Article	Prognostic Impact of the 21-Gene Recurrence Score Assay Among Young Women With Node-Negative and Node-Positive ER-Positive/HER2-Negative Breast Cancer.
Academic Article	Postpartum Involution and Cancer: An Opportunity for Targeted Breast Cancer Prevention and Treatments?
Academic Article	Intracranial Efficacy and Survival With Tucatinib Plus Trastuzumab and Capecitabine for Previously Treated HER2-Positive Breast Cancer With Brain Metastases in the HER2CLIMB Trial.
Academic Article	Clinical outcomes of breast cancer patients treated in phase I clinical trials at University of Colorado Cancer Center.
Academic Article	Evaluation of Safety of Stereotactic Body Radiotherapy for the Treatment of Patients With Multiple Metastases: Findings From the NRG-BR001 Phase 1 Trial.
Academic Article	Arm Morbidity After Local Therapy for Young Breast Cancer Patients.
Academic Article	Tucatinib versus placebo added to trastuzumab and capecitabine for patients with pretreated HER2+ metastatic breast cancer with and without brain metastases (HER2CLIMB): final overall survival analysis.
Academic Article	Tucatinib vs Placebo, Both in Combination With Trastuzumab and Capecitabine, for Previously Treated ERBB2 (HER2)-Positive Metastatic Breast Cancer in Patients With Brain Metastases: Updated Exploratory Analysis of the HER2CLIMB Randomized Clinical Trial.
Academic Article	Corrigendum to "Tucatinib versus placebo added to trastuzumab and capecitabine for patients with pretreated HER2D metastatic breast cancer with and without brain metastases (HER2CLIMB): final overall survival analysis": [Annals of Oncology 33 (2022) 321-329].

Search Criteria

Neoplasm Metastasis